Current concepts in psychodermatology

Current Psychiatry Reports

Volumn 11, Issue 3, 2009, Pages 211-218

  Locala, Joseph A ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANXIOLYTIC AGENT; ARIPIPRAZOLE; CHLORPROMAZINE; DAPSONE; DOXEPIN; DULOXETINE; ETANERCEPT; GABAPENTIN; INTERLEUKIN 1; INTERLEUKIN 10; ISOTRETINOIN; LITHIUM SALT; METHOTREXATE; NEUROLEPTIC AGENT; OLANZAPINE; PHENOTHIAZINE DERIVATIVE; PIMOZIDE; QUETIAPINE; RISPERIDONE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; STEROID; THIORIDAZINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VENLAFAXINE;

ACNE; ALOPECIA; ANXIETY; ANXIETY DISORDER; ATOPIC DERMATITIS; BODY DYSMORPHIC DISORDER; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM DEPRESSION; CHRONIC URTICARIA; COGNITIVE DEFECT; COGNITIVE THERAPY; DELIRIUM; DELUSIONS OF PARASITOSIS; DEPRESSION; DISTRESS SYNDROME; DRUG EFFICACY; DRUG ERUPTION; DRUG HALF LIFE; DRUG MECHANISM; DRUG TOLERABILITY; EMOTIONALITY; ERYTHEMA MULTIFORME; EXFOLIATIVE DERMATITIS; FOLLICULITIS; HORMONE RELEASE; HUMAN; HUMORAL IMMUNITY; HYPERHIDROSIS; HYPERPIGMENTATION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INJECTION SITE REACTION; MANIA; MELANOMA; MENTAL DISEASE; MOOD DISORDER; PHOTOSENSITIVITY; PIGMENT DISORDER; POSTHERPETIC NEURALGIA; PROTEIN EXPRESSION; PRURITUS; PSORIASIS; PSYCHOSIS; RELAXATION TRAINING; REVIEW; SIDE EFFECT; SKIN BLEEDING; SKIN DISEASE; STEVENS JOHNSON SYNDROME; SUICIDAL IDEATION; TH1 CELL; TH2 CELL; UNSPECIFIED SIDE EFFECT; URTICARIA;

ADAPTATION, PSYCHOLOGICAL; COMORBIDITY; DERMATOLOGY; HUMANS; LIFE CHANGE EVENTS; MENTAL DISORDERS; PSYCHONEUROIMMUNOLOGY; SKIN DISEASES; STRESS, PSYCHOLOGICAL;

EID: 65749116769     PISSN: 15233812     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11920-009-0033-x     Document Type: Review

References (43)

1. O'Sullivan RL, Lipper G, Lerner EA: The neuro-immunocutaneous-endocrine network: Relationship of mind and skin. Arch Dermatol 1998, 134:1431-1435.
2. Tausk F, Elenkov I, Moynihan J: Psychoneuroimmunology. Dermatol Ther 2008, 21:22-31.
3. Kronfol Z, Remick DI Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry 2000, 158:683-694.
4. Maes M, Meltzer H, Bosmans E, et al.: Increased plasma concentrations of interleukin-6, soluble interleukin-6 receptor soluble interleukin-2 receptor and transferrin receptor in major depression. J Affect Disord 1995, 34:301-309.
5. Fortune DG, Main CJ, O'Sullivan TM, et al.: Assessing illness-related stress in psoriasis: The psychometric properties of the psoriasis life stress inventory. J Psychosom Res 1997, 42:467-475.
6. Finzi A, Colombo D, Andeassi L, et al.: Psychological distress and coping strategies in patients with psoriasis: The PSYCHAE Study. J Eur Acad Dermatol Venereol 2007, 21:1161-1169.
7. Pietrzak AT, Zalewska A, Chodrowska G, et al.: Cytokines and anticytokines in psoriasis. Clin Chim Acta 2008, 394:7-21.
8. Filakovic P, Biljan DA Petek A: Depression in dermatology: an integrative perspective. Psychiatria Danubina 2008, 20:419-425.
9. Karanikas E, Harsoulis F, Giouzepas I, et al.: Neuroendocrine stimulatory tests of hypothalamus-pituitary-adrenal axis in psoriasis and correlative implications with psychopathological and immune parameters. J Dermatol 2009, 36:35-44.
10. Hashiro M, Okumura M: Anxiety, depression and psychosomatic symptoms in patients with atopic dermatitis: Comparison with normal controls and among groups of different degrees of severity. J Dermatol Sci 1997, 14:63-67.
11. Lonne-Rahm SB, Rickberg H, El Nour H, et al.: Neuroimmune mechanism in patients with atopic dermatitis during chronic stress. J Eur Acad Dermatol Venereol 2008, 22:11-18.
12. Hull PR, D'Arcy CD: Acne, depression and suicide. Dermatol Clin 2005, 23:665-674.
13. Gupta MA, Gupta AK: Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis, and psoriasis. Br J Dermatol 1998, 139:846-850.
14. Rehn LM, Meririnne E, Hook-Nikanne J, et al.: Depressive symptoms, suicidal ideation and acne: A study of male Finnish conscripts. J Eur Acad Dermatol Venereol 2008, 22:561-567.
15. Engin B, Uguz F, Yilmaz E, et al.: The levels of depression, anxiety and quality of life in patients with chronic idiopathic urticaria. J Eur Acad Dermatol Venereol 2007, 22:36-40.
16. Uguz F, Engin B, Yilmaz E: Quality of life in patients with chronic idiopathic urticaria: The impact of Axis I and Axis II psychiatric disorders. Gen Hosp Psychiatry 2008, 30:453-457
17. Kretzmer GE, Gelkopf M, Kretzmer G, et al.: Idiopathic pruritus in psychiatric inpatients: An explorative study. Gen Hosp Psychiatry 2008, 30:344-348.
18. Murase JE, Wu AJ, Koo J: Morgellons disease: a rapport-enhancing term for delusions of parasitosis. J Am Acad Dermatol 2006, 55:913-914.
19. Savely VR, Leitao MM, Stricker RB: The mystery of Morgellons disease: infection or delusion? Am J Clin Dermatol 2006, 7:1-5.
20. US Centers for Disease Control and Prevention: Unexplained dermopathy (aka "Morgellons"). Available at http://www.cdc.gov/ unexplaineddermopathy/investigation.html. Accessed March 2009.
21. Sandoz A, LoPiccolo M, Kusnir D, et al.: A clinical paradigm of delusions of parasitosis. J Am Acad Dermatol 2008, 59:698-764.
22. Thomas I, Patterson WM, Szepietowski JC, et al.: Body dysmorphic disorder: More than meets the eye. Acta Dermatovenerol Croat 2005, 13:50-53.
23. Malick F, Howard J, Koo J: Understanding the psychology of the cosmetic patients. Dermatol Ther 2008, 21:47-53.
24. Orringer JS, Helfrich YR, Hamilton T, et al.: Prevalence of psychotropic medication use among cosmetic and medical dermatology patients a comparative study. J Am Acad Dermatol 2006, 54:416-419.
25. Szepietowski JC, Salomon J, Pacan P, et al.: Body dysmorphic disorder and dermatologists. J Eur Acad Dermatol Venereol 2007, 22:795-799.
26. Robinson JK, Kim J, Rosenbaum S, et al.: Indoor tanning knowledge, attitudes and behavior among young adults from 1988 to 2007. Arch Dermatol 2008, 144:484-488.
27. Heckman CJ, Coups EJ, Manne SL: Prevalence and correlates of indoor tanning among US adults. J Am Acad Dermatol 2008, 58:769-780.
28. Feldman SR, Liguori A, Kucenic M, et al.: Ultraviolet exposure is a reinforcing stimulus in frequent indoor tanners. J Am Acad Dermatol 2004, 51:45-51.
29. Nolan BV, Feldman SR: Ultraviolet tanning addiction. Dermatol Clin 2009, 27:109-112.
30. Picardi A, Abeni D, Melchi CF, et al.: Psychiatric morbidity in dermatological outpatients: An issue to be recognized. Br J Dermatol 2000, 143:983-991.
31. Willemsen R, Roseeuw D,TVanderkinden J: Alexithymia and dermatology: the state of the art. Int J Dermatol 2008, 47:903-910.
32. Richards HL, Fortune DG, Griffiths CE, et al.: Alexithymia in patients with psoriasis. Clinical correlates and psychometric properties of the Toronto Alexithymia Scale 20. J Psychosom Res 2005, 58:89-96.
33. Asri F, Akhdari R, Chagh R, et al.: Alexithymia and depression in chronic dermatosis. Eur Psychiatry 2008, 23:S242.
34. Gupta MA, Lanius RA, Van der Kol BA: Psychologic trauma, posttraumatic stress disorder and dermatology. Dermatol Clin 2005, 23:649-656.
35. Vythilingum B, Stein D: Obsessive-compulsive disorders and dermatologic disease. Dermatol Clin 2005, 23:675-680.
36. Demet MM, Devecci A, Taskin O, et al.: Obsessive compulsive disorder in a dermatology outpatient clinic. Gen Hosp Psychiatry 2005, 27:426-430.
37. Warnock JK, Morris D: Adverse cutaneous reactions to mood stabilizers. Am J Clin Dermatol 2003, 4: 21-30.
38. Krahn LE, Goldberg RL: Psychotropic medications and the skin. In Psychotropic Drug Use in the Medically Ill. Edited by Silver PA. Basel, Switzerland: Karger; 1994:90-106.
39. Wachter T, Murach WM, Brocker EB, et al.: Recalcitrant lithium-induced psoriasis in a suicidal patient alleviated by tumour necrosis factor-alpha inhibition. Br J Dermatol 2007, 157:627-629.
40. Lee CS, Accordino R, Howard J, et al.: Psychopharmacology in dermatology. Dermatol Ther 2008, 21:69-82.
41. Koo JY, Ng TC: Psychotropic and neurotropic agents in dermatology: unapproved uses, dosages or indications. Clin Dermatol 2002, 20:582-594.
42. Gupta MA, Gupta AK, Ellis CN, Koblenzer CS: Psychiatric evaluation of the dermatology patient. Dermatol Clin 2005, 23:591-599.
43. Woodruff PWR, Higgins EM, du Vivier AW, et al.: Psychiatric illness inpatients referred to a dermatology-psychiatry clinic. Gen Hosp Psychiatry 1997, 19:29-35.